Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02731183
Other study ID # FMT-CIPO
Secondary ID
Status Completed
Phase N/A
First received April 2, 2016
Last updated August 8, 2017
Start date December 2014
Est. completion date March 2016

Study information

Verified date August 2017
Source Jinling Hospital, China
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic intestinal pseudo obstruction(CIPO) is a serious motility disorder with life-threatening condition, and it is often related with bacterial overgrowth. Fecal microbiota transplantation (FMT) results in restoration of the normal intestinal microbial community structure. The investigators planned to observe the efficacy of FMT in the treatment of a series CIPO patients. Patients received FMT on 6 consecutive days through nasojejunal tubes and followed up for 8 weeks after treatment. Rate of clinical improvement and remission, feeding tolerance of enteral nutrition, CT score of intestinal obstruction, and gastrointestinal quality-of-life index(GIQLI) were evaluated.


Recruitment information / eligibility

Status Completed
Enrollment 9
Est. completion date March 2016
Est. primary completion date September 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

Patients had to have a ?rm diagnosis diagnostic criteria for CIPO proposed by Ministry of Health, Labour, and Welfare, including documented pathological bowel dilatation on imaging in the absence of mechanical obstruction.

Exclusion Criteria:

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
fecal microbiota transplantation
Patients received frozen FMT on 6 consecutive days through nasojejunal tubes.

Locations

Country Name City State
China Department of Generay Surgery, Jinling hosptal, Medical School of Nanjing University Nanjing Jiangsu

Sponsors (1)

Lead Sponsor Collaborator
Jinling Hospital, China

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary the tolerance of enteral nutrition (EN) through nasojejunal tube We defined feeding intolerance (FI) as inability to deliver the amount of nutrient as a proportion of 'energy requirements', with values of 80% chosen, or a certain amount (750ml) per 24h. 8 weeks
Primary the time oral intake started The time when oral intake (both fluids and solid food) started was noted. 8 weeks
Secondary symptomatic relief The occurrence and severity of each of these symptoms: pain, nausea, vomiting and bloating (each scored as 0 = absent, 1 = mild, 2 = medium, 3 = severe, or 4 = could not be worse) were recorded by nurses blinded to the intervention on a daily basis. 8 weeks
Secondary scoring evaluation of abdominal CT We use a computed tomography scoring system to evaluate the severity of obstruction. 8 weeks